I
IN8bio D
D
INAB
0.26560
USD
-0.02
(-8.10%)
مغلق
حجم التداول
5,200
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
19,251,552
المقالات
العنوان: IN8bio
القطاع: Healthcare
الصناعة: Biotechnology
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.